Advantar Labs moving to new site to build CRO relationships
The analytical development and formulation service provider will use the bigger facility, which covers 18,000 square foot in California, to develop its business with CROs (contract research organisations).
“The larger facility will also allow for the development of new business relationships with a specific emphasis on collaborating with [preclinical and clinical CROs]”, Advantar Labs said in a statement.
Advantar Labs is already working with other service providers. In September it inked a non-exclusive deal with DavosPharma, a provider of discovery, chemistry, and formulation services, to collaborate on helping biopharma clients.
As well as increasing emphasis on CROs, the site will allow Advantar Labs to grow its headcount and add business with manufacturers of finished products and active pharmaceutical ingredients (APIs).
“We anticipate that the new facility will accommodate approximately 70 scientists and support staff. Strategically, this move will allow for continued growth, increased efficiency and overall lower costs for our operations”, Richard Kenley, CEO of Advantar Labs, said.
The move to the new facility began last Thursday and Advantar Labs expects the new site to open for business on Monday. After completing the move Advantar Labs will have several positions to fill and is encouraging anyone who is interested to attend its open house event in May with their résumé.